组织激肽释放酶治疗急性缺血性卒中的研究进展  

Advances in tissue kallikrein for acute ischemic stroke

作　　者：张健[1] 曾进胜[1] ZHANG Jian;ZENG Jinsheng(Department of Neurology,The First Affiliated Hospital,Sun Yat-sen University,Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases,National Key Clinical Department and Key Discipline of Neurology,No.58 Zhongshan Road 2,Guangzhou,510080,China)

机构地区：[1]中山大学附属第一医院神经科,广东省重大神经疾病诊治研究重点实验室,国家临床重点专科和国家重点学科,广州510080

出　　处：《中国神经精神疾病杂志》2025年第2期115-120,共6页Chinese Journal of Nervous and Mental Diseases

基　　金：广东省重大神经疾病诊治研究重点实验室(编号:2020B1212060017);广东省神经系统疾病临床医学研究中心(编号:2020B1111170002);华南神经疾病早期干预及功能修复研究国际联合研究中心(编号:2015B050501003,2020A0505020004);广东省神经系统重大疾病诊治工程技术研究中心;广东省神经系统重大疾病诊治转化医学创新平台和广州市神经系统重大疾病临床医学研究与转化中心(编号:201604020010)。

摘　　要：急性缺血性卒中(acute ischemic stroke,AIS)是神经科常见疾病,尽管目前诊断和治疗技术有所进步,但仍面临诸多挑战。组织激肽释放酶(tissue kallikrein,TK)作为心脑血管保护因子,参与AIS的全过程,具有重要的临床价值。本文探讨了TK在AIS中的作用机制,包括靶向改善缺血区侧支循环、保护神经血管耦联、减轻神经损伤及参与远隔缺血适应等。此外,TK水平与AIS发病及复发风险呈负相关,可作为生物标志物。TK治疗还可改善AIS患者的神经功能,降低其复发率,并可联合血管再通治疗共同改善预后。在AIS合并多器官疾病的情况下,TK也表现出良好的疗效。本文总结TK在AIS诊断、治疗及预防中的重要作用,为未来研究和临床应用提供了新的思路。Acute ischemic stroke(AIS)is a common neurological disorder that still presents many challenges despite advancements in diagnostic and therapeutic techniques.Tissue kallikrein(TK),a cardiovascular and cerebrovascular protective factor,is involved in the entire process of AIS and holds significant clinical value.This review explores the mechanisms of TK in AIS,including targeting collateral circulation improvement in ischemic areas,protecting neurovascular coupling,reducing neuronal injury,and participating in remote ischemic conditioning.Additionally,plasma TK levels are negatively correlated with AIS incidence and recurrence risk,which can serve as a potential biomarker.TK therapy has been shown to improve neurological function in AIS patients,reduce recurrence rates and enhance outcomes when combined with reperfusion therapies.TK also demonstrates therapeutic benefits in AIS patients with multiple organ comorbidities.This review concludes the important roles of TK in the diagnosis,treatment,and prevention of AIS,providing new insights for future research and clinical applications.

关 键 词：急性缺血性卒中 组织激肽释放酶 人尿激肽原酶 缺血半暗带 生物标志物 神经功能改善 心脑血管保护 

分 类 号：R743[医药卫生—神经病学与精神病学]